Liquidia Corp (LQDA)
Pharmaceutical Preparations
Latest Price
$65.72
TTM P/E
46.94
Normalized P/E
--
Div Yield
--
Book Value
2.21
P/B Ratio
29.79
Institutional Ownership
87.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10.79M | $860.0M | 12.11% | +5.30M | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 8.37M | $666.0M | 9.39% | -- | 2026-06-30 |
| Caligan Partners LP | 8.12M | $647.0M | 9.11% | -- | 2026-06-30 |
| FINDELL CAPITAL MANAGEMENT LLC | 4.80M | $382.0M | 5.39% | +1.25M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.14M | $250.0M | 3.52% | +212.2K | 2026-06-30 |
| STATE STREET CORP | 3.03M | $241.0M | 3.40% | +1.15M | 2026-06-30 |
| Opaleye Management Inc. | 2.45M | $195.0M | 2.75% | -97.5K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.12M | $169.0M | 2.38% | +192.3K | 2026-06-30 |
| BANK OF AMERICA CORP /DE/ | 1.99M | $158.0M | 2.24% | -296.2K | 2026-06-30 |
| CITADEL ADVISORS LLC | 1.95M | $155.0M | 2.18% | +30.7K | 2026-06-30 |